Renee D. Gala - 18 May 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: EVP & Chief Financial Officer
Signature: By: /s/Adam Guttmann, as attorney in fact For: Renee D Gala
Issuer symbol: JAZZ
Transactions as of: 18 May 2023
Net transactions value: -$790,474
Form type: 4
Filing time: 19 May 2023, 20:45:45 UTC
Previous filing: 07 Apr 2023
Next filing: 09 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Sale	$790,474	-6,000	-14%	$131.75	35,978	18 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.69 to $131.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Content

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.69 to $131.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.